1. Eltzschig HK, Eckle T. Ischemia and reperfusion--from mechanism to translation. Nat Med 2011; 17:1391-1401
2. Murry CE, Jennings RB, Reimer KA. Pre-conditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74:1124-1136.
3. McCully JD, Toyoda Y, Uematsu M, Stewart RD, Levitsky S. Adenosine-enhanced ischemic preconditioning: adenosine receptor involvement during ischemia and reperfusion. Am J Physiol Heart Circ Physiol 2001; 280:591-602.
4. Przyklenk K. Reduction of myocardial infarct size with ischemic “conditioning”: physiologic and technical considerations. Anesth Analg 2013; 117:891-901.
5. Randhawa PK, Jaggi AS. TRPV1 and TRPV4 channels: potential therapeutic targets for ischemic conditioning-induced cardio protection. Eur J Pharmacol 2015; 746:180–185.
6. Randhawa PK, Jaggi AS. Gadolinium and ruthenium red attenuate remote hind limb preconditioning-induced cardioprotection: possible role of TRP and especially TRPV channels. Naunyn Schmiede Arch Pharmacol 2016; 389:887–896.
7. Crimi G, Pica S, Raineri C, Bramucci E, De Ferrari GM, Klersy C et al. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial. JACC Cardiovasc Interv 2013; 6:1055-1063.
8. Gao F, Liang Y, Wang X, Lu Z, Li L, Zhu S et al. TRPV1 Activation Attenuates High-Salt Diet-Induced Cardiac 3Hypertrophy and Fibrosis through PPAR-δ Upregulation. PPAR Res 2014; 2014:491963.
9. Zhu SB, Liu Y, Zhu Y, Yin GL, Wang RP, Zhang Y et al. Remote preconditioning, perconditioning, and postconditioning: a comparative study of their cardio-protective properties in rat models. Clinics (Sao Paulo) 2013; 68:263-268.
10. Zaugg M, Schaub MC. Signaling and cellular mechanisms in cardiac protection by ischemic and pharmacological preconditioning. J Muscle Res Cell Motil 2003; 24:219-249.
11. Fudickar A, Kunath S, Voß D, Siggelkow M, Cavus E, Steinfath M et al. Effect of ischemic and pharmacological preconditioning of lower limb muscle tissue on tissue oxygenation measured by near-infrared spectroscopy--a pilot study. BMC Anesthesiol 2014; 14:54-63.
12. Ali N, Rizwi F, Iqbal A, Rashid A. Induced remote ischemic pre-conditioning on ischemia-reperfusion injury in patients undergoing coronary artery bypass. J Coll Physicians Surg Pak 2010; 20:427-431.
13. Lee KS, Lim BV, Jang MH, Shin MC, Lee TH, Kim YP et al. Hypothermia inhibits cell proliferation and nitric oxide synthase expression in rats. Neurosci Lett 2002; 329:53-56.
14. McCafferty K, Forbes S, Thiemermann C, Yaqoob MM. The challenge of translating ischemic conditioning from animal models to humans: the role of comorbidities. Dis Model Mech 2014; 7:1321-1333.
15. Voucharas C, Lazou A, Triposkiadis F, Tsilimingas N. Remote preconditioning in normal and hypertrophic rat hearts. J Cardio Thorac Surg 2011; 6:34-40.
16. Cleveland JC Jr, Meldrum DR, Cain BS, Banerjee A, Harken AH. Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited. Circulation 1997; 96:29-32.
17. Kottenberg E, Musiolik J, Thielmann M, Jakob H, Peters J, Heusch G. Interference of propofol with signal transducer and activator of transcription 5 activation and cardioprotection by remote ischemic preconditioning during coronary artery bypass grafting. J Thorac Cardiovasc Surg 2014; 147:376-382.
18. Musazzi L, Milanese M, Farisello P, Zappettini S, Tardito D, Barbiero VS, et al. Acute stress increases depolarization-evoked glutamate release in the rat prefrontal/ frontal cortex: the dampening action of antidepressants. PLoS ONE 2010; 1:8566.
19. Hasko G, Cronstein BN. Adenosine: an endogenous regulator of innate immunity. Trends Immunol 2004; 25:33–39.
20. Livingston M, Heaney LG, Ennis M. Adenosine, inflammation and asthma--a review. Inflamm Res 2004; 53:171-178.
21. Lankford AR, Yang JN, Rose’Meyer R, French BA, Matherne GP, Fredholm BB et al. Effect of modulating cardiac A1 adenosine receptor expression on protection with ischemic preconditioning. Am J Physiol Heart CircPhysiol 2006; 290:469-473.
22. Layland J, Carrick D, Lee M, Oldroyd K, Berry C. Adenosine: physiology, pharmacology, and clinical applications. JACC Cardiovasc Interv 2014; 7:581-591.
23. Singh L, Kulshrestha R, Singh N, Jaggi AS. Mechanisms involved in adenosine pharmacological preconditioning-induced cardioprotection. Korean J Physiol Pharmacol 2018; 22:225-234.
24. Randhawa PK, Jaggi AS. Investigating the involvement of TRPV1 ion channels in remote hind limb preconditioning-induced cardioprotection in rats. NaunynSchmiede. Arch Pharmacol 2017; 390:117–126.
25. Agrawal A, Jaggi AS, Singh N. Pharmacological investigations on adaptation in rats subjected to cold-water immersion stress. Physiol Behav 2011; 103:321-329.
26. Fishbein MC, Meerbaum S, Rit J, Lando U, Kanmatsuse K, Mercier JC et al. Early phase acute myocardial infarct size quantification: validation of the triphenyltetrazolium chloride tissue enzyme staining technique. Am Heart J 1981; 101:593–600.
27. Ito Y, Tamura I. Age-related changes in collagen, laminin and tenascin in the infant rat submandibular gland. J Osaka Dent Univ 1997; 31:19-27.
28. Jaggi AS, Singh M, Sharma A, Singh D, Singh N, Cardioprotective effects of mast cell modulators in ischemia-reperfusion-induced injury in rats. Methods Find Exp Clin Pharmacol 2007; 29:593-600.
29. Diwan V, Jaggi A.S, Singh M, Singh N, Singh D. Possible involvement of erythropoietin in remote renal preconditioning-induced cardioprotection in rats. J Cardiovasc Pharmacol 2008; 51:126–130.
30. King JA. A routine method for estimation of lactate dehydrogenase activity. J Med Lab Tech 1959; 16:291–332.
31. Randhawa PK, Jaggi AS. TRPV1 channels in cardiovascular system: a double-edged sword? Int J Cardiol 2017; 228:103–113.
32. Sharma R, Randhawa PK, Singh N, Jaggi AS. Possible role of thromboxane A2 in remote hind limb preconditioning-induced cardioprotection. Naunyn Schmiedebergs Arch. Pharmacol 2016; 389:1–9.
33. Singh H, Kumar M, Singh N, Jaggi AS. Late phases of cardioprotection during remote ischemic preconditioning and adenosine preconditioning involve activation of neurogenic pathway. J Cardiovasc Pharmacol 2019; 73:63-69.
34. Márquez MF, Sobrino A, Vallejo M, Hermosillo AG, Guzmán C, Férez-Santander SM et al. Diagnostic evaluation of cardiovascular autonomic function in patients with diabetes mellitus. Rev Invest Clin 2003; 55:606-615.
35. Loubani M, Fowler A, Standen NB, Galiñanes M. The effect of gliclazide and glibenclamide on preconditioning of the human myocardium. Eur J Pharmacol 2005; 515:142-149.
36. Kottenberg E, Thielmann M, Kleinb ongard P, Frey UH, Heine T, Jakob H et al. Myocardial protection by remote ischaemic pre-conditioning is abolished in sulphonyl urea-treated diabetics undergoing coronary revascularisation. Acta Anaesthesiol Scand 2014; 147:453-462.
37. Zhang J, Liu XB, Cheng C, Xu DL, Lu QH, Ji XP. Rho-kinase inhibition is involved in the activation of PI3-kinase/Akt during ischemic-preconditioning-induced cardiomyocyte apoptosis. Int J Clin Exp Med 2014; 7:4107-4114.